Filed by Enzon Pharmaceuticals, Inc.
Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934.
 	Commission File No. 000-12957 	
 	Subject Company:	Enzon Pharmaceuticals, Inc.	
 	 	NPS Pharmaceuticals, Inc.	
The following materials were used by executives of Enzon Pharmaceuticals, Inc. (“Enzon”) in connection with the announcement of the proposed business combination between Enzon and NPS Pharmaceuticals, Inc.

*	Subject to stockholder and regulatory approvals and other customary closing conditions.